Determination of cerebrospinal fluid cystatin C on Architect ci8200

Journal of Immunological Methods

Volumn 360, Issue 1-2, 2010, Pages 84-88

  Ndjole, Annaby Moussa ^a   Bodolea, Constantin ^b   Nilsen, Tom ^c   Gordh, Torsten ^a   Flodin, Mats ^a   Larsson, Anders ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b BABE BOLYAI UNIVERSITY   (Romania)

^c Gentian AS   (Norway)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Cystatin C

Indexed keywords

BILIRUBIN; CYSTATIN C; HEMOGLOBIN;

ACCURACY; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CORRELATION ANALYSIS; IMMUNOASSAY; PRIORITY JOURNAL; PROTEIN DETERMINATION; REFERENCE VALUE; ADULT; AGED; ALZHEIMER DISEASE; COMPARATIVE STUDY; COMPUTER SYSTEM; DEVICES; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING; UTILIZATION; VALIDATION STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COMPUTER SYSTEMS; CYSTATIN C; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING, COMPUTER-ASSISTED; VALIDATION STUDIES AS TOPIC;

EID: 77955663248     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.06.012     Document Type: Article

References (17)

1. Deng A., Irizarry M.C., Nitsch R.M., Growdon J.H., Rebeck G.W. Elevation of cystatin C in susceptible neurons in Alzheimer's disease. Am. J. Pathol. 2001, 159:1061.
2. Dharnidharka V.R., Kwon C., Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am. J. Kidney Dis. 2002, 40:221.
3. Gao W.M., Chadha M.S., Berger R.P., Omenn G.S., Allen D.L., Pisano M., Adelson P.D., Clark R.S., Jenkins L.W., Kochanek P.M. A gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury. J. Neurotrauma 2007, 24:43.
4. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin. Nephrol. 1992, 38(Suppl 1):20.
5. Grubb A.O. Cystatin C-properties and use as diagnostic marker. Adv. Clin. Chem. 2000, 35:63.
6. Hanrieder J., Wetterhall M., Enblad P., Hillered L., Bergquist J. Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates. J. Neurosci. Methods 2009, 177:469.
7. Kaeser S.A., Herzig M.C., Coomaraswamy J., Kilger E., Selenica M.L., Winkler D.T., Staufenbiel M., Levy E., Grubb A., Jucker M. Cystatin C modulates cerebral beta-amyloidosis. Nat. Genet. 2007, 39:1437.
8. Levy E., Sastre M., Kumar A., Gallo G., Piccardo P., Ghetti B., Tagliavini F. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J. Neuropathol. Exp. Neurol. 2001, 60:94.
9. Mi W., Pawlik M., Sastre M., Jung S.S., Radvinsky D.S., Klein A.M., Sommer J., Schmidt S.D., Nixon R.A., Mathews P.M., Levy E. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models. Nat. Genet. 2007, 39:1440.
10. Palsdottir A., Abrahamson M., Thorsteinsson L., Arnason A., Olafsson I., Grubb A., Jensson O. Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 1988, 2:603.
11. Pasinetti G.M., Ungar L.H., Lange D.J., Yemul S., Deng H., Yuan X., Brown R.H., Cudkowicz M.E., Newhall K., Peskind E., Marcus S., Ho L. Identification of potential CSF biomarkers in ALS. Neurology 2006, 66:1218.
12. Piubelli C., Fiorini M., Zanusso G., Milli A., Fasoli E., Monaco S., Righetti P.G. Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping. Proteomics 2006, 6(Suppl 1):S256-S261.
13. Ranganathan S., Williams E., Ganchev P., Gopalakrishnan V., Lacomis D., Urbinelli L., Newhall K., Cudkowicz M.E., Brown R.H., Bowser R. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J. Neurochem. 2005, 95:1461.
14. Shimode K., Fujihara S., Nakamura M., Kobayashi S., Tsunematsu T. Diagnosis of cerebral amyloid angiopathy by enzyme-linked immunosorbent assay of cystatin C in cerebrospinal fluid. Stroke 1991, 22:860.
15. Sundelof J., Arnlov J., Ingelsson E., Sundstrom J., Basu S., Zethelius B., Larsson A., Irizarry M.C., Giedraitis V., Ronnemaa E., German-Gunnarsson M., Hyman B.T., Basun H., Kilander L., Lannfelt L. Serum cystatin C and the risk of Alzheimer disease in elderly men. Neurology 2008, 71:1072.
16. Vinters H.V., Nishimura G.S., Secor D.L., Pardridge W.M. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. Am. J. Pathol. 1990, 137:233.
17. Yang Y., Liu S., Qin Z., Cui Y., Qin Y., Bai S. Alteration of cystatin C levels in cerebrospinal fluid of patients with Guillain-Barre syndrome by a proteomical approach. Mol. Biol. Rep. 2009, 36:677.